Effects of hexadecylphosphocholine on thrombocytopoiesis

European Journal of Cancer

Volumn 37, Issue 4, 2001, Pages 503-511

  Berkovic, D ^a,b   Bensch, M ^a   Bertram, J ^a   Wille, T ^a   Haase, D ^a   Binder, C ^a   Fleer, E A M ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Klinik Maria Hilf   (Germany)

Author keywords

Alkylphosphocholines; Ether lipids; Hexadecylphosphocholine; Thrombocytopoiesis

Indexed keywords

CELL EXTRACT; ETHERLYSOPHOSPHOLIPID; HEMOPOIETIC GROWTH FACTOR; MESSENGER RNA; MILTEFOSINE; PHOSPHOLIPID DERIVATIVE; PHOSPHORYLCHOLINE; THROMBOPOIETIN; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CANCER PATIENT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FIBROBLAST; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SUPERNATANT; THROMBOCYTOPOIESIS;

ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; CELL DIVISION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; PHOSPHORYLCHOLINE; RNA, MESSENGER; THROMBOCYTOSIS; TUMOR CELLS, CULTURED;

EID: 0035087308     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00394-4     Document Type: Article

References (35)

1. Selective destruction of human leukemic cells by alkyl-lysophospholipids
2. Selective sensitivity of chronic myelogenous leukemia cell populations to alkyl-lysophospholipids
3. The influence of alkyl-phospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3 Lewis Lung carcinomas
4. Early tumor and leukemia response to alkyl-lysophospholipids in a phase I study
5. Cytotoxicity of alkyl-lysophospholipids derivatives and low alkyl-cleavage enzyme activities in rat brain tumor cells
6. Hexadecylphosphocholine (D18506) in the topical treatment of skin metastases: A phase I trial
7. Hexadecylphosphocholine in the treatment of skin metastasis in breast cancer patients
8. Phase II trial of orally administered miltefosine in advanced colorectal cancer
9. Phase II study of daily oral hexadecylphosphocholine in advanced colorectal cancer
10. Daily oral miltefosine (hexadecylphosphocholine) in patients with advanced non small cell lung cancer. A phase II study
11. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas
12. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in leukemic cells
13. Induction of differentiation of cultured mouse myeloid leukemia cells by alkyllysophospholipids
14. Effects of neoplastic phospholipids on parameters of cell differentiation in U937 cells
15. Antiinvasive activity of hexadecylphosphocholine in vitro
16. Hexadecylphosphocholine-mediated enhancement of T-cell responses to interleukin 2
17. Hexadecylphosphocholine induces interferon-gamma secretion and expression of GM-CSF m RNA in human mononuclear cells
18. Disturbance of phospholipid metabolism during selective destruction of tumor cells induced by alkylphospholipids
19. Effects of hexa-decylphosphocholine on protein kinase C and TPA-induced differentiation of HL 60 cells
20. Inhibition of protein kinase C (sodium plus potassium) activated adenosine triphosphatase and sodium pump by synthetic phospholipid analogues
21. Selective inhibitation of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues
22. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine specific phospholipase C in human leukemia cells
23. 2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine
24. Alkyllysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis
25. Increases in leucocyte and patelet counts induced by the alkyl-phospholipid hexadecylphosphocholine
26. Effects of ether lipids on mouse granulocyte macrophage progenitor cells
27. 3)
28. Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine
29. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid
30. Different mechanisms of inhibitation by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony stimulating factor binding to human leukemic cell lines
31. Identification of functional platelet-activating factor receptors in Raji lymphoblasts
32. Investigations on the cellular uptake of hexadecylphosphocholine
33. Hexadecylphosphocholine: Oral treatment of visceral leishmaniasis in mice
34. Miltefosine, an oral agent, for the treatment of indian visceral leishmaniasis
35. Visceral leishmaniasis activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms